These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 19208651)

  • 21. Comparison of pathways controlling toxicity in the eye and brain in Drosophila models of human neurodegenerative diseases.
    Ghosh S; Feany MB
    Hum Mol Genet; 2004 Sep; 13(18):2011-8. PubMed ID: 15254017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice.
    Emamian ES; Kaytor MD; Duvick LA; Zu T; Tousey SK; Zoghbi HY; Clark HB; Orr HT
    Neuron; 2003 May; 38(3):375-87. PubMed ID: 12741986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. USP7, a ubiquitin-specific protease, interacts with ataxin-1, the SCA1 gene product.
    Hong S; Kim SJ; Ka S; Choi I; Kang S
    Mol Cell Neurosci; 2002 Jun; 20(2):298-306. PubMed ID: 12093161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis.
    Williams AJ; Knutson TM; Colomer Gould VF; Paulson HL
    Neurobiol Dis; 2009 Mar; 33(3):342-53. PubMed ID: 19084066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity.
    Jana NR; Tanaka M; Wang Gh; Nukina N
    Hum Mol Genet; 2000 Aug; 9(13):2009-18. PubMed ID: 10942430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract.
    Yue S; Serra HG; Zoghbi HY; Orr HT
    Hum Mol Genet; 2001 Jan; 10(1):25-30. PubMed ID: 11136710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-chaperone HSJ1a dually regulates the proteasomal degradation of ataxin-3.
    Gao XC; Zhou CJ; Zhou ZR; Zhang YH; Zheng XM; Song AX; Hu HY
    PLoS One; 2011; 6(5):e19763. PubMed ID: 21625540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sacs R272C missense homozygous mice develop an ataxia phenotype.
    Larivière R; Sgarioto N; Márquez BT; Gaudet R; Choquet K; McKinney RA; Watt AJ; Brais B
    Mol Brain; 2019 Mar; 12(1):19. PubMed ID: 30866998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chaperone suppression of cellular toxicity of huntingtin is independent of polyglutamine aggregation.
    Zhou H; Li SH; Li XJ
    J Biol Chem; 2001 Dec; 276(51):48417-24. PubMed ID: 11606565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential of indole and a synthetic derivative for polyQ aggregation reduction by enhancement of the chaperone and autophagy systems.
    Lin CH; Wu YR; Kung PJ; Chen WL; Lee LC; Lin TH; Chao CY; Chen CM; Chang KH; Janreddy D; Lee-Chen GJ; Yao CF
    ACS Chem Neurosci; 2014 Oct; 5(10):1063-74. PubMed ID: 25197952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The J Domain of Sacsin Disrupts Intermediate Filament Assembly.
    Dabbaghizadeh A; Paré A; Cheng-Boivin Z; Dagher R; Minotti S; Dicaire MJ; Brais B; Young JC; Durham HD; Gentil BJ
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of sacsin levels in peripheral blood mononuclear cells as a diagnostic tool for spastic ataxia of Charlevoix-Saguenay.
    De Ritis D; Ferrè L; De Winter J; Tremblay-Desbiens C; Blais M; Bassi MT; Dupré N; Baets J; Filippi M; Maltecca F
    Brain Commun; 2024; 6(4):fcae243. PubMed ID: 39091421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-omic profiling reveals the ataxia protein sacsin is required for integrin trafficking and synaptic organization.
    Romano LEL; Aw WY; Hixson KM; Novoselova TV; Havener TM; Howell S; Taylor-Blake B; Hall CL; Xing L; Beri J; Nethisinghe S; Perna L; Hatimy A; Altadonna GC; Graves LM; Herring LE; Hickey AJ; Thalassinos K; Chapple JP; Wolter JM
    Cell Rep; 2022 Nov; 41(5):111580. PubMed ID: 36323248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ubiquitin-conjugating enzyme UbcH6 regulates the transcriptional repression activity of the SCA1 gene product ataxin-1.
    Lee S; Hong S; Kang S
    Biochem Biophys Res Commun; 2008 Aug; 372(4):735-40. PubMed ID: 18519031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial dysfunction and Purkinje cell loss in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS).
    Girard M; Larivière R; Parfitt DA; Deane EC; Gaudet R; Nossova N; Blondeau F; Prenosil G; Vermeulen EG; Duchen MR; Richter A; Shoubridge EA; Gehring K; McKinney RA; Brais B; Chapple JP; McPherson PS
    Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1661-6. PubMed ID: 22307627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical shift assignment of the ataxin-1 AXH domain in complex with a CIC ligand peptide.
    de Chiara C; Kelly G; Menon RP; McCormick J; Pastore A
    Biomol NMR Assign; 2014 Oct; 8(2):325-7. PubMed ID: 23853075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteasome function is inhibited by polyglutamine-expanded ataxin-1, the SCA1 gene product.
    Park Y; Hong S; Kim SJ; Kang S
    Mol Cells; 2005 Feb; 19(1):23-30. PubMed ID: 15750336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine D2 receptor signaling modulates mutant ataxin-1 S776 phosphorylation and aggregation.
    Hearst SM; Lopez ME; Shao Q; Liu Y; Vig PJ
    J Neurochem; 2010 Aug; 114(3):706-16. PubMed ID: 20477910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and functional analysis of ataxin-2 and ataxin-3.
    Albrecht M; Golatta M; Wüllner U; Lengauer T
    Eur J Biochem; 2004 Aug; 271(15):3155-70. PubMed ID: 15265035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila.
    Chan HY; Warrick JM; Gray-Board GL; Paulson HL; Bonini NM
    Hum Mol Genet; 2000 Nov; 9(19):2811-20. PubMed ID: 11092757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.